IBDEI1GO ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26203,0)
 ;;=496.^^150^1595^17
 ;;^UTILITY(U,$J,358.3,26203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26203,1,3,0)
 ;;=3^Chr Airway Obstruction NEC
 ;;^UTILITY(U,$J,358.3,26203,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,26203,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,26204,0)
 ;;=585.3^^150^1595^21
 ;;^UTILITY(U,$J,358.3,26204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26204,1,3,0)
 ;;=3^Chr Kidney Disease,Stage III
 ;;^UTILITY(U,$J,358.3,26204,1,4,0)
 ;;=4^585.3
 ;;^UTILITY(U,$J,358.3,26204,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,26205,0)
 ;;=585.4^^150^1595^22
 ;;^UTILITY(U,$J,358.3,26205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26205,1,3,0)
 ;;=3^Chr Kidney Disease,Stage IV
 ;;^UTILITY(U,$J,358.3,26205,1,4,0)
 ;;=4^585.4
 ;;^UTILITY(U,$J,358.3,26205,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,26206,0)
 ;;=585.1^^150^1595^19
 ;;^UTILITY(U,$J,358.3,26206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26206,1,3,0)
 ;;=3^Chr Kidney Disease,Stage I
 ;;^UTILITY(U,$J,358.3,26206,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,26206,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,26207,0)
 ;;=585.2^^150^1595^20
 ;;^UTILITY(U,$J,358.3,26207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26207,1,3,0)
 ;;=3^Chr Kidney Disease,Stage II
 ;;^UTILITY(U,$J,358.3,26207,1,4,0)
 ;;=4^585.2
 ;;^UTILITY(U,$J,358.3,26207,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,26208,0)
 ;;=585.5^^150^1595^23
 ;;^UTILITY(U,$J,358.3,26208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26208,1,3,0)
 ;;=3^Chr Kidney Disease,Stage V
 ;;^UTILITY(U,$J,358.3,26208,1,4,0)
 ;;=4^585.5
 ;;^UTILITY(U,$J,358.3,26208,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,26209,0)
 ;;=585.9^^150^1595^18
 ;;^UTILITY(U,$J,358.3,26209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26209,1,3,0)
 ;;=3^Chr Kidney Disease NOS
 ;;^UTILITY(U,$J,358.3,26209,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,26209,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,26210,0)
 ;;=428.0^^150^1595^26
 ;;^UTILITY(U,$J,358.3,26210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26210,1,3,0)
 ;;=3^Congestive Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,26210,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,26210,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,26211,0)
 ;;=414.01^^150^1595^27
 ;;^UTILITY(U,$J,358.3,26211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26211,1,3,0)
 ;;=3^Cor Atheroscl Native Vessel
 ;;^UTILITY(U,$J,358.3,26211,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,26211,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,26212,0)
 ;;=585.6^^150^1595^35
 ;;^UTILITY(U,$J,358.3,26212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26212,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,26212,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,26212,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,26213,0)
 ;;=401.9^^150^1595^41
 ;;^UTILITY(U,$J,358.3,26213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26213,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,26213,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,26213,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,26214,0)
 ;;=250.00^^150^1595^28
 ;;^UTILITY(U,$J,358.3,26214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26214,1,3,0)
 ;;=3^DM Type II w/o Complications
 ;;^UTILITY(U,$J,358.3,26214,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,26214,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,26215,0)
 ;;=907.2^^150^1595^45
 ;;^UTILITY(U,$J,358.3,26215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26215,1,3,0)
 ;;=3^Late Effect SCI
 ;;^UTILITY(U,$J,358.3,26215,1,4,0)
 ;;=4^907.2
 ;;^UTILITY(U,$J,358.3,26215,2)
 ;;=^275240
 ;;^UTILITY(U,$J,358.3,26216,0)
 ;;=724.2^^150^1595^47
 ;;^UTILITY(U,$J,358.3,26216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26216,1,3,0)
 ;;=3^Low Back Pain
